Stefania Pizzimenti
Turin, 10125, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 58 publications
Correction: Exposure of HL-60 human leukaemic cells to 4-hydroxynonenal promotes the formation of adduct(s) with α-enolase devoid of plasminogen binding activity.
Journal: The Biochemical journal
Published: June 03, 2026
Erratum to "Gemcitabine-loaded ICOS-Fc decorated nanosponges: a new chemo immunotherapy combination against pancreatic cancer". [Int. J. Pharm. 682 (2025) 125869].
Journal: International journal of pharmaceutics
Published: January 15, 2026
Exploring Anti-Neoplastic Activity of Chitosan Nanobubbles Decorated with ICOS-Fc and Loaded with Paclitaxel in a Human and Murine Model of Melanoma.
Journal: Pharmaceutics
Published: October 14, 2025
Methanol Extract from Ranunculus repens L. Down-Regulated Galectins 4 and 9, and Mitigated Chronic Pancreatitis in an Experimental Rat Model.
Journal: Antioxidants (Basel, Switzerland)
Published: September 25, 2025
Balancing the Cellular Inflammatory-Homeostatic Axis Through Natural Ingredient Supplementation.
Journal: Nutrients
Published: June 26, 2025
Gemcitabine-loaded ICOS-Fc decorated nanosponges: A new chemo immunotherapy combination against pancreatic cancer.
Journal: International journal of pharmaceutics
Published: February 20, 2025
Ultrasmall solid lipid nanoparticles as a potential innovative delivery system for a drug combination against glioma.
Journal: Nanomedicine (London, England)
Published: November 29, 2024
Discovery of a septin-4 covalent binder with antimetastatic activity in a mouse model of melanoma.
Journal: Bioorganic chemistry
Published: December 06, 2023
The HDAC inhibitor romidepsin renders liver cancer vulnerable to RTK targeting and immunologically active.
Journal: Nature communications
Published: July 13, 2023
Nrf2 as a Therapeutic Target in the Resistance to Targeted Therapies in Melanoma.
Journal: Antioxidants (Basel, Switzerland)
Published: May 25, 2023
Use of Poly Lactic-co-glycolic Acid Nano and Micro Particles in the Delivery of Drugs Modulating Different Phases of Inflammation.
Journal: Pharmaceutics
Published: April 29, 2023
Last Updated: 09/26/2026